Epilepsy with auditory features: Contribution of known genes in 112 patients.


Journal

Seizure
ISSN: 1532-2688
Titre abrégé: Seizure
Pays: England
ID NLM: 9306979

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 12 10 2020
revised: 23 11 2020
accepted: 24 12 2020
pubmed: 17 1 2021
medline: 10 7 2021
entrez: 16 1 2021
Statut: ppublish

Résumé

Epilepsy with Auditory Features (EAF) is a focal epilepsy syndrome mainly of unknown aetiology. LGI1 and RELN have been identified as the main cause of Autosomal Dominant EAF and anecdotally reported in non-familial cases. Pathogenic variants in SCN1A and DEPDC5 have also been described in a few EAF probands belonging to families with heterogeneous phenotypes and incomplete penetrance. We aimed to estimate the contribution of these genes to the disorder by evaluating the largest cohort of EAF. We included 112 unrelated EAF cases (male/female: 52/60) who underwent genetic analysis by next-generation sequencing (NGS) techniques. Thirty-three (29.5%) were familial cases. We identified a genetic diagnosis for 8% of our cohort, including pathogenic/likely pathogenic variants (4/8 novel) in LGI1 (2.7%, CI: 0.6-7.6); RELN (1.8%; CI: 0.2-6.3); SCN1A (2.7%; CI: 0.6-7.6) and DEPDC5 (0.9%; CI 0-4.9).This study shows that the contribution of each of the known genes to the overall disorder is limited and that the genetic background of EAF is still largely unknown. Our data emphasize the genetic heterogeneity of EAF and will inform the diagnosis and management of individuals with this disorder.

Identifiants

pubmed: 33453592
pii: S1059-1311(20)30412-X
doi: 10.1016/j.seizure.2020.12.015
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

115-118

Informations de copyright

Copyright © 2020 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Auteurs

F Bisulli (F)

IRCCS Istituto delle Scienze Neurologiche di Bologna, Epilepsy Center (Full Member of the ERN EpiCARE), Bologna, Italy; Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy. Electronic address: francesca.bisulli@unibo.it.

C Rinaldi (C)

IRCCS Istituto delle Scienze Neurologiche di Bologna, Epilepsy Center (Full Member of the ERN EpiCARE), Bologna, Italy; Neurological Clinic, Department of Experimental and Clinical Medicine, Marche Polytechnic University, Ancona, Italy.

T Pippucci (T)

Medical Genetic Unit, Sant'Orsola Malpighi Hospital, Bologna, Italy.

R Minardi (R)

IRCCS Istituto delle Scienze Neurologiche di Bologna, Epilepsy Center (Full Member of the ERN EpiCARE), Bologna, Italy.

S Baldassari (S)

IRCCS Istituto delle Scienze Neurologiche di Bologna, Epilepsy Center (Full Member of the ERN EpiCARE), Bologna, Italy; Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, F-75013, Paris, France.

C Zenesini (C)

IRCCS Istituto delle Scienze Neurologiche di Bologna, Epilepsy Center (Full Member of the ERN EpiCARE), Bologna, Italy.

B Mostacci (B)

IRCCS Istituto delle Scienze Neurologiche di Bologna, Epilepsy Center (Full Member of the ERN EpiCARE), Bologna, Italy.

M Fanella (M)

Department of Human Neurosciences, "Sapienza" University of Rome and Policlinico Umberto I, Italy.

P Avoni (P)

IRCCS Istituto delle Scienze Neurologiche di Bologna, Epilepsy Center (Full Member of the ERN EpiCARE), Bologna, Italy; Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.

V Menghi (V)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.

L Caporali (L)

IRCCS Istituto delle Scienze Neurologiche di Bologna, Epilepsy Center (Full Member of the ERN EpiCARE), Bologna, Italy.

L Muccioli (L)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.

P Tinuper (P)

IRCCS Istituto delle Scienze Neurologiche di Bologna, Epilepsy Center (Full Member of the ERN EpiCARE), Bologna, Italy; Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.

L Licchetta (L)

IRCCS Istituto delle Scienze Neurologiche di Bologna, Epilepsy Center (Full Member of the ERN EpiCARE), Bologna, Italy; Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH